Sign in

CIK 0001070494 · Large accelerated filer

ACADIA PHARMACEUTICALS INC

Sign in to watch
Ticker
ACAD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
061376651
Phone
858-558-2871
Business address
12830 EL CAMINO REAL, SUITE 400, SAN DIEGO, CA, 92130
  1. 10-Q Report Quarterly Report
  2. 8-K Event Results of operations
  3. 4 Open-market sale EVP, CHIEF FINANCIAL OFFICER sold 975 shares at $14.79 ($14,420)
  4. 4 Option exercise Director acquired 6,652 shares (option exercise)
  5. 4 Option exercise Director acquired 6,652 shares (option exercise)
  6. 4 Option exercise Director acquired 6,652 shares (option exercise)
  7. 4 Option exercise Director acquired 6,652 shares (option exercise)
  8. 4 Option exercise Director acquired 6,652 shares (option exercise)
  9. 4 Option exercise Director acquired 6,652 shares (option exercise)
  10. 4 Grant or award Director acquired 37,548 shares (grant or award)
  11. 8-K Event Executive or director change · Shareholder vote results
  12. S-8 POS Other Post-effective Amendment
  13. S-8 POS Other Post-effective Amendment
  14. S-8 POS Other Post-effective Amendment
  15. S-8 POS Other Post-effective Amendment
  16. S-8 POS Other Post-effective Amendment
  17. S-8 POS Other Post-effective Amendment
  18. S-8 POS Other Post-effective Amendment
  19. S-8 POS Other Post-effective Amendment
  20. S-8 POS Other Post-effective Amendment

Page 8 of 70 · 1,382 filings